Skip to main content

Thailand receives 1st batch of COVID-19 vaccines from China’s Sinovac

Abstract : The first batch of COVID-19 vaccines that Thailand ordered from China's Sinovac Biotech arrived in the capital Bangkok Wednesday, putting the country on track to kickstart its national inoculation program.

Thai Prime Minister Prayut Chan-o-cha (11th L), Deputy Prime Minister and Public Health Minister Anutin Charnvirakul (10th L), Chinese Embassy official Yang Xin (9th R) and other guests pose for group photos during a handover ceremony for the first batch of COVID-19 vaccines at Suvarnabhumi Airport in Bangkok, Thailand, Feb. 24, 2021. The first batch of COVID-19 vaccines that Thailand ordered from China’s Sinovac Biotech arrived in the capital Bangkok Wednesday, putting the country on track to kickstart its national inoculation program. (Xinhua/Zhang Keren)

BANGKOK, Feb. 24 (Xinhua) — The first batch of COVID-19 vaccines that Thailand ordered from China’s Sinovac Biotech arrived in the capital Bangkok Wednesday, putting the country on track to kickstart its national inoculation program.

The 200,000 doses, the first shipment among 2 million doses Thailand ordered from the Chinese biopharmaceutical firm, were delivered by a Thai Airways International cargo flight from Beijing to Bangkok.

Thai Prime Minister Prayut Chan-o-cha, Deputy Prime Minister and Public Health Minister Anutin Charnvirakul, as well as Chinese Embassy official Yang Xin were at the airport for the handover of the vaccines.

“Today is a historic day with the reception of the first lot of vaccine,” Prayut said at the vaccine handover ceremony, expressing his gratitude for China’s timely delivering of the vaccines.

“Without any unexpected problems, subsequent lots will arrive as planned,” he said.

Calling it another major progress in bilateral anti-pandemic cooperation, Yang Xin said he hoped the Sinovac vaccines would play an active role in supporting Thailand’s fight against COVID-19.

Thailand approved the Sinovac vaccine for emergency use on Monday, and the authorization will be valid for one year, according to Anutin.

Upon the vaccines’ arrival, three days would be required for the final inspection before the national vaccination campaign begins, Prayut said.

The first batch of the Sinovac vaccines will be distributed to 13 provinces, including Bangkok, and administered to at-risk groups, including medical workers, close contacts with COVID-19 patients and people with certain chronic illnesses.

A second batch of 800,000 doses of the Sinovac vaccines is scheduled to arrive in Thailand next month, followed by a third batch of the remaining 1 million doses.

Thailand has set a three-staged national inoculation program, aiming to vaccinate enough of the general population to create herd immunity. Besides the Sinovac vaccines, it would also use AstraZeneca vaccines.

As of Wednesday, the Southeast Asian nation’s total COVID-19 tally rose to 25,692, with more than four-fifths of the infections being detected since the new wave of outbreak erupted in the country in mid-December. Enditem

About Xinhua Silk Road

Xinhua Silk Road (en.imsilkroad.com) is the Belt and Road Initiative (BRI) portal.China’s silk road economic belt and the 21st century maritime silk road website,includes BRI Policy, BRI Trade, BRI Investment, Belt and Road weekly, Know Belt and Road, and the integrated information services for the Belt and Road Initiative (BRI).

Source: Thailand receives 1st batch of COVID-19 vaccines from China’s Sinovac

Labels:

Comments

Post a Comment

Popular posts from this blog

Singapore’s manufacturing output declines 0.9 pct on year in October

Abstract : Singapore Economic Development Board announced on Thursday that the country's manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. SINGAPORE, Nov. 26 (Xinhua) — Singapore Economic Development Board announced on Thursday that the country’s manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. Excluding biomedical manufacturing, the output fell 2.7 percent in October from a year ago. On a seasonally adjusted month-on-month basis, Singapore’s manufacturing output decreased 19 percent in October. Excluding biomedical manufacturing, the output fell 2.9 percent. As for the performance of different clusters, the electronics cluster’s output fell 0.6 percent year on year in October, compared to a revised 33.1 percent increase in September. The biomedical manufacturing cluster saw its output grow 10.2 percent in October, compared to a revi...
Post a Comment
Read more

China’s Greater Bay Area to take lead in traditional medicines

Abstract : Guangdong, Hong Kong and Macao will strengthen cooperation in building a "highland" for the traditional Chinese medicine (TCM) sector, according to an official plan unveiled on Thursday. GUANGZHOU, Oct. 23 (Xinhua) — Guangdong, Hong Kong and Macao will strengthen cooperation in building a “highland” for the traditional Chinese medicine (TCM) sector, according to an official plan unveiled on Thursday. The plan was jointly released by the National Administration of Traditional Chinese Medicine, the office of the leading group for the development of the Guangdong-Hong Kong-Macao Greater Bay Area and the provincial government of Guangdong. According to the plan, the bay area aims to take the lead in innovation, industry development and personnel training of TCM, as well as promoting its internationalization. The region plans to build a group of high-level TCM hospitals by 2022 and help several well-known local TCM brands enter the global market. By 2025, the inter...
Post a Comment
Read more

Economic Watch: China’s industrial profits rebound, pressure persists

Abstract : Profits of China's major industrial firms rebounded in the second quarter (Q2) as business activities continued to pick up, but the recovery still faces uncertainties due to the global spread of COVID-19. BEIJING, July 27 (Xinhua) — Profits of China’s major industrial firms rebounded in the second quarter (Q2) as business activities continued to pick up, but the recovery still faces uncertainties due to the global spread of COVID-19 . In Q2, profits of industrial companies with annual revenue of more than 20 million yuan (about 2.86 million U.S. dollars) rose by 4.8 percent year on year, reversing the 36.7-percent decline in Q1, the National Bureau of Statistics (NBS) said on Monday. In June alone, major industrial firms saw their profits rise by 11.5 percent to 666.55 billion yuan, widening by 5.5 percentage points from that in May, said NBS senior statistician Zhu Hong. The quickened growth in industrial production and sales, as well as the moderate drop in the fa...
Post a Comment
Read more